Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Published Febraury 2023 - can this help TH's case?
View:
Post by Joemare on Apr 04, 2023 10:58am

Published Febraury 2023 - can this help TH's case?

Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways

J Infect Dis   2023 Feb 14;227(4):565-576. doi: 10.1093/infdis/jiac475
Comment by Joemare on Apr 04, 2023 11:05am
Authors...... Lindsay T Fourman 1, Takara L Stanley 1, Mollie W Ockene 1, Colin M McClure 1, Mabel Toribio 1, Kathleen E Corey 2, Raymond T Chung 2, Martin Torriani 3, David E Kleiner 4, Colleen M Hadigan 5, Steven K Grinspoon 
Comment by Wino115 on Apr 04, 2023 2:30pm
It's the Grinspoon lab team, they continue to reserach EGRIFTA and NASH/NAFLD for both HIV and non-HIV. It just adds more scientific data and possibly could be used by the MSLs in talking about the drug to clinics. It may add a bit more rationale if someone with HIV is starting to show NASH symptoms.  
Comment by scarlet1967 on Apr 04, 2023 3:33pm
https://stockhouse.com/companies/bullboard/t.th/theratechnologies-inc?postid=35199516
Comment by Joemare on Apr 04, 2023 4:30pm
Indeed!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse